Bruce Wendel

CIK: 0001364846

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

PDSB

PDS Biotechnology Corp

Director

IBRX

ImmunityBio, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

PDSB
PDS Biotechnology Corp
Oct 18, 2026
Award(A)
Stock Option (Right to Buy)
Direct
22.7K shares-
IBRX
ImmunityBio, Inc.
Jun 9, 2026
Award(A)
Stock Option (right to buy)
Direct
65.6K shares-
IBRX
ImmunityBio, Inc.
Dec 12, 2025
Award(A)
Stock Option (right to buy)
Direct
146K shares-

		Type	Shares	Price		Ownership
Oct 18, 2026	PDSB PDS Biotechnology Corp	Award(A) Stock Option (Right to Buy)	22,700	-	-	Direct
Jun 9, 2026	IBRX ImmunityBio, Inc.	Award(A) Stock Option (right to buy)	65,600	-	-	Direct
Dec 12, 2025	IBRX ImmunityBio, Inc.	Award(A) Stock Option (right to buy)	146,020	-	-	Direct

1-3 of 3 transactions

About Wendel Bruce

Wendel Bruce (SEC CIK 0001364846) files insider reports with the SEC as Director of PDS Biotechnology Corp (PDSB) and Director of ImmunityBio, Inc. (IBRX).

Signal8 holds 5 ownership filings by Wendel Bruce (2 Form 3, 3 Form 4), filed between Dec 16, 2025 and Oct 20, 2026. Those filings report 3 transactions, from Dec 12, 2025 to Oct 18, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Wendel Bruce's filings is in PRINCETON, NJ.

Recent filings by Wendel Bruce

Oct 18, 2026: Grant or award of PDSB derivative securities (Form 4, code A).
Jun 9, 2026: Grant or award of IBRX derivative securities (Form 4, code A).
Dec 12, 2025: Grant or award of IBRX derivative securities (Form 4, code A).

Other insiders filing for PDS Biotechnology Corp (PDSB)

Dawson John Andrew, Director
Ramsdell Deborah, Director
SOON-SHIONG PATRICK, Director
Banaag Arnold James, Director
Trochimiuk Janetta, Principal Accounting Officer
BEDU-ADDO FRANK, President/CEO

How to read Form 4 transaction codes